Fibrosis-4 Index (FIB-4)
Guideline-recommended first-line nonproprietary blood score combining age, AST, ALT, and platelet count to estimate advanced liver fibrosis risk.
FIB-4 is the single most practical number you can calculate right from your routine lab results (CMP + CBC). One important detail for older adults: because age is multiplied on the top of the fraction, FIB-4 naturally creeps upward as we get older. In people 65 and up, studies propose raising the low-risk cutoff from 1.3 to 2.0 so you don't get false alarms based on birthday candles alone — while in people under 35, FIB-4 can under-call risk and shouldn't be trusted by itself if metabolic risk is high.
What Is FIB-4?
- A nonproprietary score using age, AST, ALT, and platelet count1,2
- Estimates the likelihood of advanced liver fibrosis (≥F3) in patients with suspected liver disease1,2
Use in MASLD/MASH Care
- FIB-4 is strongly recommended by current guidelines as a risk stratification tool in primary care to identify patients suitable for ongoing monitoring versus those needing specialist referral2,5-7
How Is It Measured?
- FIB-4 is calculated using the formula below2
- FIB-4 calculation is also offered at a nominal cost at many laboratories2,3
Strengths
- Accessible, guideline-endorsed1,2,5-7
- Calculators are widely available and built into some EMRs1
- Supports identification of patients with elevated risk who should be referred and/or further evaluated to stage liver fibrosis5
Limitations
- Age <18 years (Pediatric): strictly contraindicated — Age in the numerator causes severe false-negative scores in children and adolescents9
- Age ≥65 years: reduced specificity (apply a higher <2.0 FIB-4 low-risk cutoff)4,5
- Age <35 years: reduced accuracy5
- Secondary assessment recommended in patients <35 years old with higher metabolic risk or elevated liver enzymes5
- FIB-4 <1.3 may miss 20%–30% of biopsy-proven F2–F3 MASH in Type 2 diabetes8
Interactive FIB-4 Index Calculator
100% Private • Runs in BrowserEnter values from a recent Comprehensive Metabolic Panel (AST, ALT) and Complete Blood Count (Platelets). Built-in guardrails enforce pediatric contraindications (<18 y) and AASLD/EASL age-adjusted thresholds (≥65 y).
Proposed Age Range–Specific Cutoffs for FIB-44,5
| Age Group | Absence of Advanced Fibrosis | Further Investigation (Indeterminate) | Advanced Fibrosis (≥F3) Likely |
|---|---|---|---|
| <18 y (Pediatric) | Contraindicated — use sex-specific ALT (≥50 U/L boys, ≥44 U/L girls) + pediatric imaging9 | ||
| 18–34 y (Young Adult) | Reduced sensitivity due to young age; if T2D, obesity, or elevated ALT is present, consider SAFE score or elastography directly5 | ||
| 35–64 y | <1.3 | 1.3–2.67 | >2.67 |
| ≥65 y | <2.0 | 2.0–2.67 | >2.67 |